Cue Biopharma Q3 EPS $(4.74) Misses $(2.24) Estimate, Sales $132.000K Miss $1.033M Estimate
Benzinga Newsdesk 3 days ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(4.74) per share which missed the analyst consensus estimate of $(2.24) by 111.61 percent. This is a 113.51 percent decrease over losses of $(2.22) per share from
Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(4.74) per share which missed the analyst consensus estimate of $(2.24) by 111.61 percent. This is a 113.51 percent decrease over losses of $(2.22) per share from the same period last year. The company reported quarterly sales of $132.000 thousand which missed the analyst consensus estimate of $1.033 million by 87.23 percent. This is a 93.86 percent decrease over sales of $2.149 million the same period last year.
